Cargando…

The Clinical Relevance and Immune Correlation of SLC10 Family Genes in Liver Cancer

BACKGROUND AND AIM: This study was aimed to reveal the clinical relevance and immune correlation of the SLC10 family genes in liver cancer. METHODS: A comprehensive bioinformatics analysis was utilized to determine the gene expression, genetic alterations, DNA methylation, clinical significance, sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Shan, Li, Jiao, Xiang, Jiankang, Peng, Pailan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809167/
https://www.ncbi.nlm.nih.gov/pubmed/36606115
http://dx.doi.org/10.2147/JHC.S392586
_version_ 1784863066758840320
author Tian, Shan
Li, Jiao
Xiang, Jiankang
Peng, Pailan
author_facet Tian, Shan
Li, Jiao
Xiang, Jiankang
Peng, Pailan
author_sort Tian, Shan
collection PubMed
description BACKGROUND AND AIM: This study was aimed to reveal the clinical relevance and immune correlation of the SLC10 family genes in liver cancer. METHODS: A comprehensive bioinformatics analysis was utilized to determine the gene expression, genetic alterations, DNA methylation, clinical significance, survival association and immune correlation of seven SLC10 family genes in liver cancer. The multiplexed immunohistochemical technique was applied to determine the association between SLC10A3 protein expression and immune cells, and the correlation between SLC10A3 protein and immune checkpoints (PD1 and PD-L1) in a cohort of 32 individuals with liver cancer. RESULTS: The expression of SLC10 family genes was different between normal liver tissues and malignant liver tissues. SLC10A5 showed the highest alteration rate (8%), followed by SLC10A3 (2.8%). Low expression of SLC10A1 was indicative of poor tumor grade and advanced tumor stage in liver cancer. Scatter plots uncovered that expression of SLC10A3 was inversely associated with SLC10A1 and SLC10A5 expression in liver cancer. The expression of SLC10A1 and SLC10A5 was strongly associated with their DNA methylation. SLC10A1 expression was a reliable genetic biomarker for the prediction of survival outcomes in liver cancer population. Expression of SLC10 family genes was remarkably linked with the abundance of most immune infiltrating cells in liver cancer, and SLC10A3 was the most significant member. The multiplexed immunohistochemical technique confirmed that there existed the significant correlations between SLC10A3 protein expression and CD4 T cells, CD20 B cells and the close association with PD-1 in the stromal area from malignant tissues. CONCLUSION: The expressions of SLC10 family genes were different between normal liver tissues and malignant liver tissues, and they were correlated with each other in liver cancer. SLC10A1 possesses the most significant correlation with survival outcomes. SLC10A3 exhibited the most significant relationship with immune cells, as revealed by bioinformatics analysis and multispectral imaging technique.
format Online
Article
Text
id pubmed-9809167
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-98091672023-01-04 The Clinical Relevance and Immune Correlation of SLC10 Family Genes in Liver Cancer Tian, Shan Li, Jiao Xiang, Jiankang Peng, Pailan J Hepatocell Carcinoma Original Research BACKGROUND AND AIM: This study was aimed to reveal the clinical relevance and immune correlation of the SLC10 family genes in liver cancer. METHODS: A comprehensive bioinformatics analysis was utilized to determine the gene expression, genetic alterations, DNA methylation, clinical significance, survival association and immune correlation of seven SLC10 family genes in liver cancer. The multiplexed immunohistochemical technique was applied to determine the association between SLC10A3 protein expression and immune cells, and the correlation between SLC10A3 protein and immune checkpoints (PD1 and PD-L1) in a cohort of 32 individuals with liver cancer. RESULTS: The expression of SLC10 family genes was different between normal liver tissues and malignant liver tissues. SLC10A5 showed the highest alteration rate (8%), followed by SLC10A3 (2.8%). Low expression of SLC10A1 was indicative of poor tumor grade and advanced tumor stage in liver cancer. Scatter plots uncovered that expression of SLC10A3 was inversely associated with SLC10A1 and SLC10A5 expression in liver cancer. The expression of SLC10A1 and SLC10A5 was strongly associated with their DNA methylation. SLC10A1 expression was a reliable genetic biomarker for the prediction of survival outcomes in liver cancer population. Expression of SLC10 family genes was remarkably linked with the abundance of most immune infiltrating cells in liver cancer, and SLC10A3 was the most significant member. The multiplexed immunohistochemical technique confirmed that there existed the significant correlations between SLC10A3 protein expression and CD4 T cells, CD20 B cells and the close association with PD-1 in the stromal area from malignant tissues. CONCLUSION: The expressions of SLC10 family genes were different between normal liver tissues and malignant liver tissues, and they were correlated with each other in liver cancer. SLC10A1 possesses the most significant correlation with survival outcomes. SLC10A3 exhibited the most significant relationship with immune cells, as revealed by bioinformatics analysis and multispectral imaging technique. Dove 2022-12-30 /pmc/articles/PMC9809167/ /pubmed/36606115 http://dx.doi.org/10.2147/JHC.S392586 Text en © 2022 Tian et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Tian, Shan
Li, Jiao
Xiang, Jiankang
Peng, Pailan
The Clinical Relevance and Immune Correlation of SLC10 Family Genes in Liver Cancer
title The Clinical Relevance and Immune Correlation of SLC10 Family Genes in Liver Cancer
title_full The Clinical Relevance and Immune Correlation of SLC10 Family Genes in Liver Cancer
title_fullStr The Clinical Relevance and Immune Correlation of SLC10 Family Genes in Liver Cancer
title_full_unstemmed The Clinical Relevance and Immune Correlation of SLC10 Family Genes in Liver Cancer
title_short The Clinical Relevance and Immune Correlation of SLC10 Family Genes in Liver Cancer
title_sort clinical relevance and immune correlation of slc10 family genes in liver cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809167/
https://www.ncbi.nlm.nih.gov/pubmed/36606115
http://dx.doi.org/10.2147/JHC.S392586
work_keys_str_mv AT tianshan theclinicalrelevanceandimmunecorrelationofslc10familygenesinlivercancer
AT lijiao theclinicalrelevanceandimmunecorrelationofslc10familygenesinlivercancer
AT xiangjiankang theclinicalrelevanceandimmunecorrelationofslc10familygenesinlivercancer
AT pengpailan theclinicalrelevanceandimmunecorrelationofslc10familygenesinlivercancer
AT tianshan clinicalrelevanceandimmunecorrelationofslc10familygenesinlivercancer
AT lijiao clinicalrelevanceandimmunecorrelationofslc10familygenesinlivercancer
AT xiangjiankang clinicalrelevanceandimmunecorrelationofslc10familygenesinlivercancer
AT pengpailan clinicalrelevanceandimmunecorrelationofslc10familygenesinlivercancer